Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation
Abstract Halting breast cancer metastatic relapses following primary tumor removal and the clinical dormant phase, remains challenging, due to a lack of specific vulnerabilities to target during dormancy. To address this, we conducted genome-wide CRISPR screens on two breast cancer cell lines with distinct dormancy properties: 4T1 (short-term dormancy) and 4T07 (prolonged dormancy). We discovered that loss of class-III PI3K, Pik3c3, revealed a unique vulnerability in 4T07 cells. Surprisingly, dormancy-prone 4T07 cells exhibited higher mTORC1 activity than 4T1 cells, due to lysosome-dependent signaling occurring at the cell periphery. Pharmacological inhibition of Pik3c3 counteracted this phenotype in 4T07 cells, and selectively reduced metastasis burden only in the 4T07 dormancy prone model. This mechanism was also detected in xenografts from human breast cancer patients, supporting that it may be relevant in humans. Our findings suggest dormant cancer cell-initiated metastasis may be prevented in patients carrying tumor cells that display PIK3C3-peripheral lysosomal signaling to mTORC1.Teaser PIK3C3-mTORC1 signaling is a novel druggable pathway in breast cancer metastasis..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 11. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Elkholi, Islam E. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.08.02.551681 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI040424634 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI040424634 | ||
| 003 | DE-627 | ||
| 005 | 20231205144456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230806s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.08.02.551681 |2 doi | |
| 035 | |a (DE-627)XBI040424634 | ||
| 035 | |a (biorXiv)10.1101/2023.08.02.551681 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Elkholi, Islam E. |e verfasserin |0 (orcid)0000-0002-8019-2481 |4 aut | |
| 245 | 1 | 0 | |a Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Halting breast cancer metastatic relapses following primary tumor removal and the clinical dormant phase, remains challenging, due to a lack of specific vulnerabilities to target during dormancy. To address this, we conducted genome-wide CRISPR screens on two breast cancer cell lines with distinct dormancy properties: 4T1 (short-term dormancy) and 4T07 (prolonged dormancy). We discovered that loss of class-III PI3K, Pik3c3, revealed a unique vulnerability in 4T07 cells. Surprisingly, dormancy-prone 4T07 cells exhibited higher mTORC1 activity than 4T1 cells, due to lysosome-dependent signaling occurring at the cell periphery. Pharmacological inhibition of Pik3c3 counteracted this phenotype in 4T07 cells, and selectively reduced metastasis burden only in the 4T07 dormancy prone model. This mechanism was also detected in xenografts from human breast cancer patients, supporting that it may be relevant in humans. Our findings suggest dormant cancer cell-initiated metastasis may be prevented in patients carrying tumor cells that display PIK3C3-peripheral lysosomal signaling to mTORC1.Teaser PIK3C3-mTORC1 signaling is a novel druggable pathway in breast cancer metastasis. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Robert, Amélie |0 (orcid)0000-0002-7235-0881 |4 aut | |
| 700 | 1 | |a Kuasne, Hellen |4 aut | |
| 700 | 1 | |a Drapela, Stanislav |0 (orcid)0000-0002-9421-9972 |4 aut | |
| 700 | 1 | |a Macleod, Graham |0 (orcid)0000-0001-6401-9307 |4 aut | |
| 700 | 1 | |a Hébert, Steven |4 aut | |
| 700 | 1 | |a Pacis, Alain |0 (orcid)0000-0003-4883-6176 |4 aut | |
| 700 | 1 | |a Calderon, Virginie |4 aut | |
| 700 | 1 | |a Kleinman, Claudia L. |4 aut | |
| 700 | 1 | |a Gomes, Ana P. |4 aut | |
| 700 | 1 | |a Aguirre-Ghiso, Julio A. |0 (orcid)0000-0002-6694-6507 |4 aut | |
| 700 | 1 | |a Park, Morag |0 (orcid)0000-0001-5400-606X |4 aut | |
| 700 | 1 | |a Angers, Stéphane |0 (orcid)0000-0001-7241-9044 |4 aut | |
| 700 | 1 | |a Côté, Jean-François |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 11. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:11 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.08.02.551681 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 11 |c 08 | ||